Related Experiment Video
Updated: Jul 9, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation
Yien Che Tsai1, Arnulfo Mendoza, Jennifer M Mariano
1Laboratory of Protein Dynamics and Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.
Abstract:
Metastasis is the primary cause of mortality from cancer, but the mechanisms leading to metastasis are poorly understood. In particular, relatively little is known about metastasis in cancers of mesenchymal origins, which are known as sarcomas. Approximately ten proteins have been characterized as 'metastasis suppressors', but how these proteins function and are regulated is, in general, not well understood. Gp78 (also known as AMFR or RNF45) is a RING finger E3 ubiquitin ligase that is integral to the endoplasmic reticulum (ER) and involved in ER-associated degradation (ERAD) of diverse substrates. Here we report that expression of gp78 has a causal role in the metastasis of an aggressive human sarcoma and that this prometastatic activity requires the E3 activity of gp78. Further, gp78 associates with and targets the transmembrane metastasis suppressor, KAI1 (also known as CD82), for degradation. Suppression of gp78 increases KAI1 abundance and reduces the metastatic potential of tumor cells, an effect that is largely blocked by concomitant suppression of KAI1. An inverse relationship between these proteins was confirmed in a human sarcoma tissue microarray. Whereas most previous efforts have focused on genetic mechanisms for the loss of metastasis suppressor genes, our results provide new evidence for post-translational downregulation of a metastasis suppressor by its ubiquitin ligase, resulting in abrogation of its metastasis-suppressing effects.
Insights
This study reveals that gp78 E3 ubiquitin ligase promotes sarcoma metastasis by degrading the KAI1 metastasis suppressor. Inhibiting gp78 increases KAI1 levels, reducing cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Metastasis is the main cause of cancer mortality, particularly in sarcomas.
- Mechanisms of metastasis, especially in sarcomas, are poorly understood.
- Metastasis suppressor proteins' functions and regulation are not well characterized.
Purpose of the Study:
- Investigate the role of gp78 (AMFR/RNF45) in sarcoma metastasis.
- Determine if gp78's E3 ligase activity is required for its prometastatic function.
- Elucidate the mechanism by which gp78 influences metastasis, focusing on its interaction with metastasis suppressors.
Main Methods:
- Assessed the role of gp78 expression in human sarcoma metastasis.
- Examined the requirement of gp78's E3 ligase activity for metastasis.
- Investigated the interaction between gp78 and the KAI1 (CD82) metastasis suppressor.
- Analyzed KAI1 protein levels and sarcoma cell metastatic potential upon gp78 modulation.
- Confirmed the inverse relationship between gp78 and KAI1 in human sarcoma tissues.
Main Results:
- Gp78 expression causally promotes metastasis in aggressive human sarcoma.
- Gp78's prometastatic activity is dependent on its E3 ligase activity.
- Gp78 targets the transmembrane metastasis suppressor KAI1 for degradation.
- Suppressing gp78 increases KAI1 abundance and reduces tumor cell metastatic potential.
- Concomitant suppression of KAI1 largely blocks the effect of gp78 suppression on metastasis.
Conclusions:
- Gp78 acts as a prometastatic factor in human sarcoma by targeting KAI1 for degradation.
- This study demonstrates post-translational downregulation of a metastasis suppressor by its ligase.
- Results highlight a novel mechanism of metastasis regulation in sarcomas, distinct from genetic loss of suppressor genes.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
PI3K/mTOR/AKT Signaling Pathway
Anaphase Promoting Complex
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation